Merck & Co

Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117 in January 2021. Schrodinger’s artificial intelligence (AI) powered software technology platform utilizes physics-based modeling and sophisticated machine learning algorithms to help clients identify the suitable molecules to treat the desired ailments.…

Artificial Intelligence (AI) in Pharmaceutical Market The global Artificial Intelligence (AI) in Pharmaceutical Market was valued at USD 905.91 million in 2022 and is expected to reach over USD 9,241.34 million by 2030, poised to grow at a compound annual growth rate (CAGR) of +29% from 2023 to 2030.Artificial intelligence in pharmaceutics has grown over…

Nuray Yurt, Merck’s business engagement and activation lead for digital data and analytics, told In Vivo about her hopes for the future of AI regulation and how stakeholders ought to reframe their understanding of the sector.

(Bloomberg) -- Palantir Technologies Inc. rallied as much as 21% in premarket trading Tuesday after giving a strong earnings forecast and saying that demand for its new artificial intelligence tool due this month is “without precedent.” Most Read from Bloomberg The company posted a surprise profit in the first quarter and expects to stay in…

Joint study showcases the synergy between experimental expertise and advanced computational methods in drug development. SHENZHEN , China and DARMSTADT, Germany , April 14, 2023 /PRNewswire/ -- Science and technology company Merck and XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, have jointly published a study that highlights…

Merck and XtalPi Inc., a pharmaceutical technology company powered by artificial intelligence (AI) and automation, jointly published a study that highlights the benefits of combining computational workflows with wet lab experiments to advance drug development.Traditional methods like milling and micronization, used to address undesirable crystal morphologies, can be disruptive and costly. Molecular dynamics simulations offer…

Courtesy of Merck Merck, a German multinational science and technology company, and Intel have agreed to jointly fund an academic research program in Europe aimed at promoting sustainable semiconductor manufacturing solutions using artificial intelligence (AI) and machine learning technologies.  The program will run for three years and focus on driving innovation in semiconductor manufacturing processes and…

JW Pharmaceutical said on Monday that it would develop raw materials for new drug candidates with Merck Life Science using an artificial intelligence (AI) platform based on a mutual business agreement. JW Pharmaceutical Head of Raw Material Research Center, Jin Se-ho (left), and Merck Life Science & Lab Solutions Business CEO Lee Nam-gu show the signed…

“Absci really wants to become the Google Index search of protein-based drug discovery and biomanufacturing for large pharmas and biotechs,” founder and CEO Sean McClain declared to GEN Edge. Since it was established in 2011, Absci’s ambition has encompassed partnering with large biopharmas to use its artificial intelligence (AI) drug discovery platform to help them…

Merck Digital Sciences Studio, a collaboration between Merck, Microsoft for Startups and the New Jersey Innovation Institute, has officially launched, according to a Friday announcement. The collaborative cohort located in Newark and Cambridge, Massachusetts, will focus on important and disruptive biotechnical approaches in artificial intelligence and machine learning, with expertise and tools from clinical scientists…

BigHat Biosciences, Inc., a biotechnology company with a machine learning-guided antibody discovery and development platform, today announced a collab

Courtesy of Getty Images BigHat Biosciences will team up with Merck Research Laboratories to design candidates for up to three drug discovery programs backed by the company’s proprietary artificial intelligence technology platform. Bay Area-based BigHat, founded in 2019, will use its machine learning-enhanced Milliner design program to “synthesize, express, purify, and characterize molecules” for Merck.…